Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-23 Option Award | 2022-06-27 5:44 pm | N/A 2032-06-23 | Ensysce Biosciences Inc. | ENSC | Martin Steven Robert Director | 15,000 | $0 | 100,850 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-04 3:22 pm | N/A 2032-02-04 | Ensysce Biosciences Inc. | ENSC | Martin Steven Robert Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 6:09 pm | N/A 2030-08-09 | Ensysce Biosciences Inc. | ENSC | Martin Steven Robert Director | 65,850 | $0 | 65,850 (Direct) | View |
| 2021-03-25 Option Award | 2021-03-26 7:33 pm | N/A 2031-03-25 | Armata Pharmaceuticals Inc. | ARMP | Martin Steven Robert Chief Financial Officer | 56,000 | $0 | 56,000 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 4:08 pm | N/A 2030-12-08 | Armata Pharmaceuticals Inc. | ARMP | Martin Steven Robert Chief Financial Officer | 23,000 | $0 | 23,000 (Direct) | View |
| 2019-05-22 Option Award | 2019-05-24 9:30 pm | N/A 2029-05-22 | Armata Pharmaceuticals Inc. | ARMP | Martin Steven Robert Chief Financial Officer | 149,362 | $0 | 149,362 (Direct) | View |